$GPCR 4/A SEC Filings

Filed On	Filing
20 Mar 2024	Form 4/A: Lin Xichen, CHIEF SCIENTIFIC OFFICER Granted 213,486 Stock Option (right to buy)
20 Mar 2024	Form 4/A: Bach Mark Allen, CHIEF MEDICAL OFFICER Granted 65,352 Stock Option (right to buy)
20 Mar 2024	Form 4/A: Ma Yingli, CHIEF TECHNOLOGY OFFICER Granted 91,494 Stock Option (right to buy)
20 Mar 2024	Form 4/A: Yoon Jun, CHIEF FINANCIAL OFFICER Granted 148,134 Stock Option (right to buy)
20 Mar 2024	Form 4/A: Stevens Raymond C, Director Granted 335,481 Stock Option (right to buy)

Comments